Bevacizumab Maly

2 indexed presentations.

Reference only for licensed healthcare facilities. These listings support NDC-level identification and quote review, and do not imply current stock, manufacturer sponsorship, or direct purchasing status. Review NDC-level listings, compare package configurations, and request a quote review when needed.

Need a Product Not Listed?

Submit a quote review for unlisted NDCs, item codes, or alternate product presentations.

Drug Directory A-Z | Drug names: B | Drug Search | Request a Quote Review

Generic details

Review dosage forms, strengths, package variations, and manufacturer identifiers associated with Bevacizumab Maly.

  • Indexed presentation count: 2 indexed presentations.
  • Common dosage forms: Injection.

Common presentations

Compare presentation differences here, then open the table rows below for NDC-level confirmation.

  • Strength variation: 100 mg / 4mL and 400 mg / 16mL.
  • Package variation: 1 Vial.
  • Manufacturer information is shown for product identification only.

Official references

Use official label-search references for this generic family when your team needs supplemental labeling context.

Showing page 1 of 1
Alymsys - Bevacizumab-maly 100 mg / 4mL Injection 4 mL70121-1754-01100 mg / 4mLInjection1 Vial
Alymsys - Bevacizumab-maly 400 mg / 16mL Injection 16 mL70121-1755-01400 mg / 16mLInjection1 Vial

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.